Physician profile
Walter A Hollinger
NPI 1679663405
$322.27
in general payments reported to CMS, 2019-2025
7 companies · $19.50 in 2025
The $19.50 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2023: $34.05 · 2024: $162 · 2025: $19.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.99 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $141.02 | 2019-2024 | Xarelto |
| Exact Sciences Corporation | $78.12 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $27.38 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.20 | 2024 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Novo Nordisk INC | $19.50 | 2025 | Ozempic, Rybelsus |
| Amgen INC. | $14.43 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Hollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.